000299011 001__ 299011
000299011 005__ 20251109023606.0
000299011 0247_ $$2doi$$a10.1186/s13053-024-00301-8
000299011 0247_ $$2pmid$$apmid:39985094
000299011 0247_ $$2ISSN$$a1731-2302
000299011 0247_ $$2ISSN$$a1897-4287
000299011 0247_ $$2altmetric$$aaltmetric:174942032
000299011 037__ $$aDKFZ-2025-00421
000299011 041__ $$aEnglish
000299011 082__ $$a610
000299011 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$eFirst author$$udkfz
000299011 245__ $$aAge-specific familial risks in cancer as clues to germline genetic and environmental causes: focus on colorectal, endometrial, prostate, kidney, breast and lung cancers.
000299011 260__ $$aHeidelberg$$bSpringer$$c2025
000299011 3367_ $$2DRIVER$$aarticle
000299011 3367_ $$2DataCite$$aOutput Types/Journal article
000299011 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762435169_1579195$$xReview Article
000299011 3367_ $$2BibTeX$$aARTICLE
000299011 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000299011 3367_ $$00$$2EndNote$$aJournal Article
000299011 500__ $$a#EA:Z999#EA:C020#
000299011 520__ $$aThe Swedish Family-Cancer Database (FCD) is the largest source of data on familial cancer in the world, including practically complete family structures and individual cancer diagnoses from the high-quality cancer registry. We present a novel application of FCD by analyzing age-specific familial risks and interpreting them through likely causes, such as germline pathogenic variants and/or environmental exposures.The basic assumption for this approach is that a discrete familial clustering in a narrow age-interval is not random but may provide causal clues. For this analysis we selected reasonably common cancers to meaningfully scrutinize familial risk through adulthood in which cancers are diagnosed, that included colorectal (CRC) and endometrial cancers, prostate and kidney cancers and breast and lung cancers. The interpretation is based on the literature. The highest familial relative risks for CRC and endometrial cancers were found at ages 40-44 years, matching the peak impact of mismatch repair gene mutations. However endometrial cancer showed also a small early onset component which could not be explained. Age-related familial risks for breast, prostate and kidney cancers also matched data from large-scale sequencing; these included the early onset component in kidney cancer which was likely due to VHL mutations. Age distribution of familial lung cancer was unique in showing a wide peak extending from middle to old ages, which would be consistent with a combination of direct genetic effects and indirect influence on inheritance of smoking dependence.The present review of age-specific familial risks and age-of-onset data from the literature may allow an interpretation that the familial and germline landscapes are reasonably harmonious for relatively early onset cancers but at higher ages no discrete peaks can be found which may implicate attenuated impact of high-risk genes and polygenic influence.
000299011 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000299011 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000299011 650_7 $$2Other$$aAge of onset
000299011 650_7 $$2Other$$aEarly onset
000299011 650_7 $$2Other$$aFamilial risk
000299011 650_7 $$2Other$$aGermline genetics
000299011 650_7 $$2Other$$aHeredity
000299011 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b1
000299011 7001_ $$aHemminki, Otto$$b2
000299011 7001_ $$aScott, Rodney J$$b3
000299011 7001_ $$aHemminki, Akseli$$b4
000299011 773__ $$0PERI:(DE-600)2233352-6$$a10.1186/s13053-024-00301-8$$gVol. 23, no. 1, p. 7$$n1$$p7$$tHereditary cancer in clinical practice$$v23$$x1731-2302$$y2025
000299011 909CO $$ooai:inrepo02.dkfz.de:299011$$pVDB
000299011 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000299011 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000299011 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000299011 9141_ $$y2025
000299011 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:39:48Z
000299011 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:39:48Z
000299011 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2024-04-10T15:39:48Z
000299011 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHERED CANCER CLIN PR : 2022$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-16
000299011 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-16
000299011 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebs$$x0
000299011 9201_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x1
000299011 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x2
000299011 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x3
000299011 9200_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x0
000299011 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebs$$x1
000299011 980__ $$ajournal
000299011 980__ $$aVDB
000299011 980__ $$aI:(DE-He78)C020-20160331
000299011 980__ $$aI:(DE-He78)Z999-20160331
000299011 980__ $$aI:(DE-He78)B062-20160331
000299011 980__ $$aI:(DE-He78)HD01-20160331
000299011 980__ $$aUNRESTRICTED